Letter to the editor in response to the article "Clinical characteristics and risk factors for low dose methotrexate toxicity: a cohort of 28 patients" by Kivity S, Zafrir Y, Loebstein R, Pauzner R, Mouallem M, Mayan H, Autoimmun Rev. 2014 Nov.;13(11):1109-13: Height of MTX-PG levels in low-dose MTX-toxicity differs according to the time of onset.

Autor: Wassenaar S; Department of Hospital Pharmacy, Erasmus MC, Postbus 2040, 3000 CA Rotterdam, The Netherlands; Department of Hospital Pharmacy, Sint Franciscus Gasthuis, Postbus 10900, 3004 BA Rotterdam, The Netherlands., den Boer E; Department of Clinical Chemistry, Erasmus MC, Postbus 2040, 3000 CA Rotterdam, The Netherlands., Westerman EM; Department of Hospital Pharmacy, Sint Franciscus Gasthuis, Postbus 10900, 3004 BA Rotterdam, The Netherlands., Hazes JM; Department of Rheumatology, Erasmus MC, Postbus 2040, 3000 CA Rotterdam, The Netherlands., de Jonge R; Department of Clinical Chemistry, Erasmus MC, Postbus 2040, 3000 CA Rotterdam, The Netherlands. Electronic address: r.dejonge1@vumc.nl.

Publikováno v: Autoimmunity reviews [Autoimmun Rev] 2016 Nov; Vol. 15 (11), pp. 1109-1110. Date of Electronic Publication: 2016 Apr 16.

Re: First vaginal delivery at an older age: does it carry an extra risk for the development of stress urinary incontinence? Groutz A, Helpman L, Gold R, Pauzner D, Lessing JB, Gordon D. 2007. Neurourol Urodyn 26:779-782.

Autor: Fritel X, Fauconnier A

Publikováno v: Neurourology and urodynamics [Neurourol Urodyn] 2009; Vol. 28 (4), pp. 365-6.

False‐positive tests for heparin‐induced thrombocytopenia in patients with antiphospholipid syndrome and systemic lupus erythematosus

Autor: R Pauzner, Karina Althaus, Boris Shenkman, Kathleen Selleng, Andreas Greinacher, Uri Seligsohn

Publikováno v: Journal of Thrombosis and Haemostasis. 7:1070-1074

Summary. Background: Heparin-induced thrombocytopenia (HIT) is a severe complication of heparin therapy that can be associated with arterial or venous thrombosis and is caused by antibodies against platelet factor 4 (PF4)–heparin complex. Patients

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fb5c89f059c436a90cd64bd97f4e7cd
https://doi.org/10.1111/j.1538-7836.2009.03335.x

Familial Mediterranean FeVer gene (MEFV) mutations as a modifier of systemic lupus erythematosus

Autor: Pnina Langevitz, Avi Livneh, Merav Lidar, E Kosach, Gisele Zandman-Goddard, Yael Shinar, Einat Rabinovich, R Pauzner

Publikováno v: Lupus. 21(9)

The objective of this study was to assess the prevalence of the Mediterranean FeVer ( MEFV) gene mutations in systemic lupus erythematosus (SLE) patients and their effect on organ involvement, as well as disease activity and severity. The frequencies

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc090733c4c7ea2977ae55d7e8723ae2
https://pubmed.ncbi.nlm.nih.gov/22532615

Letters to the editor

Autor: Joaqu�n Arenas, Rosa A. Huertas, Yolanda Campos, Ana Cabello, Eduardo Gutierrez, Juan Bautista, Dolores Segura, R. Pauzner, I. Blatt, M. Mouallem, Z. Farfel, M. Sadeh, Michel Magistris, G�rard Roth, Gareth J. G. Parry, Peter Vieregge, Gregor Bein

Publikováno v: Muscle & Nerve. 15:1055-1059

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1c4cd5fc0bb75cfa9a4fe987b9df7bbb
https://doi.org/10.1002/mus.880150911